Wearable device for prevention of postoperative and post-discharge hypoxemia: A randomized pilot trial.

ABSTRACT:

Background

The Oxalert Enhanced Pulse Oximeter (EPO) is a wearable device that detects and alerts patients to hypoxemia. In a preplanned pilot trial, we estimated the effect of continuous saturation monitoring with patient alerts on in-hospital and post-discharge saturation; we further assessed the feasibility of the intervention.

Methods

Noncardiac surgical patients were randomized to either the Oxalert with patient alerts (Monitor + Alert, N = 25) or the Oxalert without patient alerts (Monitor Only, N = 24). Monitoring continued during hospitalization for up to 6 days and for 24 h after hospital discharge. Patients in each group were compared on time-weighted average (TWA) SpO₂ <90% (%) and area under SpO₂ <90% (% * min) in-hospital and after discharg

SUBMITTER: Li K 

PROVIDER: S-EPMC10262214 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature